Australia's largest stock trading and investment forum Australia's #1 stock forum

ME1

Click for more information

0.00%

0.1¢ melodiol global health limited

I could not agree more with you! It will take a little more...

First 34 Last

Share
Profile

Follow
MichaelAppleby

280 Posts.

134

01/08/23

12:29

Post #: 69098770
Share

Originally posted by Wedgeman7: ↑

Your thought process is on the money Michael. It won’t be long before Melodiol gets traction and it hits investors radar. We are almost there. Cash flow positive and reasonable profits are around the next bend in my humble opinion. As long as William Lay continues to deliver growth opportunities whilst managing costs effectively, then we will all breath easy.
Based on the past 2 years this business has drastically transformed into an attractive investment proposition.
The next Senate sitting is early September and with a little luck they will pass SAFE banking and we will report 3rd quarter results with some wind in the sail. Markets are looking better every month. It’s our time.

Expand

I could not agree more with you! It will take a little more time, but William Lay has a clear path to take. If he doesn't, and the company returns to its old ways, get out as soon as possible, or else we will all have some very expensive virtual toilet paper. The reward will be great for those willing to take the risk, and all eyes are on the next quarterly for us.

GLTOH & DYOR!!!

ME1 Price at posting: 1.0¢ Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BUX

Buxton projects new graphite province discovery at WA Narryer play

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 56 more messages in this thread...

First 34 Last

Add ME1 (ASX) to my watchlist